Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) Net Margin (2019 - 2025)

Outset Medical (OM) has disclosed Net Margin for 7 consecutive years, with 67.5% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 1950.0% to 67.5% in Q4 2025 year-over-year; TTM through Dec 2025 was 68.34%, a 4422.0% increase, with the full-year FY2025 number at 68.34%, up 4422.0% from a year prior.
  • Net Margin was 67.5% for Q4 2025 at Outset Medical, down from 60.61% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 59.01% in Q2 2025 to a low of 174.96% in Q2 2022.
  • A 5-year average of 117.16% and a median of 124.01% in 2024 define the central range for Net Margin.
  • Biggest YoY gain for Net Margin was 19168bps in 2021; the steepest drop was -18889bps in 2021.
  • Outset Medical's Net Margin stood at 146.46% in 2021, then grew by 12bps to 129.48% in 2022, then increased by 2bps to 126.53% in 2023, then skyrocketed by 31bps to 87.01% in 2024, then rose by 22bps to 67.5% in 2025.
  • Per Business Quant, the three most recent readings for OM's Net Margin are 67.5% (Q4 2025), 60.61% (Q3 2025), and 59.01% (Q2 2025).